The Role of Endothelin-1 in Sickle Cell Disease
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Gilead Sciences
Related studies linked through entity extraction aliases.
Efficacy, Safety, and Tolerability of Ledipasvir/Sofosbuvir (LDV/SOF) Treatment for HIV/HCV Co-infected Participants Who Switch to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) or Emtricitabine/Rilpivirine/Tenofovir Alafenamide (F/R/TAF) Prior to LDV/SOF HCV Treatment
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Tolerability of Entospletinib in Combination With Systemic Corticosteroids as First-Line Therapy in Adults With Chronic Graft Versus Host Disease (cGVHD)
- Status
- TERMINATED
- Phase
- PHASE2
Study to Investigate the Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Subjects With Chronic Genotype 1 and 4 HCV Infection With Autoimmune Disease
- Status
- UNKNOWN
- Phase
- PHASE4
Sequential Regimen of Bendamustin-Debulking Followed by Ofatumumab and Ibrutinib in CLL Patients (CLL2-BIO)
- Status
- COMPLETED
- Phase
- PHASE2
Chronic Hepatitis B and C Recall Northern Holland
- Status
- UNKNOWN
- Phase
- N/A
Study of Hepatitis C Treatment During Pregnancy
- Status
- COMPLETED
- Phase
- PHASE1
CAMELLIA: Anti-CD47 Antibody Therapy in Haematological Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Participants With Chronic HCV
- Status
- COMPLETED
- Phase
- PHASE3
HIV Drug Switch Followed by HCV Therapy in HIV-HCV Co-Infection
- Status
- COMPLETED
- Phase
- PHASE3
Immediate Initiation of Antiretroviral Therapy During "Hyperacute" HIV Infection
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
Study in Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GS-9674 (Cilofexor), and the Effect of Food on GS-9674 Pharmacokinetics and Pharmacodynamics
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Efficacy of Switching to a FDC of B/F/TAF From E/C/F/TAF, E/C/F/TDF, or ATV+RTV+FTC/TDF in Virologically Suppressed HIV-1 Infected Women
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Efficacy of SOF/VEL/VOX FDC for 8 Weeks and SOF/VEL for 12 Weeks in Adults Chronic Genotype 3 HCV Infection and Cirrhosis
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Efficacy of SOF/VEL/VOX FDC for 12 Weeks and SOF/VEL for 12 Weeks in DAA-Experienced Adults With Chronic HCV Infection Who Have Not Received an NS5A Inhibitor
- Status
- COMPLETED
- Phase
- PHASE3
Therapy With Ledipasvir/Sofosbuvir in Patients With Genotype 1 HCV Infection Receiving Opiate Substitution Therapy
- Status
- UNKNOWN
- Phase
- PHASE4
Study to Evaluate Safety and Pharmacokinetics of GS-4059 (Tirabrutinib) in Healthy Volunteers and Participants With Rheumatoid Arthritis (RA)
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Patients
- Status
- RECRUITING
- Phase
- N/A
A Quality Improvement Approach to the Management of Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- NA
Switching From a Tenofovir Disoproxil Fumarate (TDF) Containing Regimen to Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Alafenamide (E/C/F/TAF) Fixed-Dose Combination (FDC) in Virologically-Suppressed, HIV-1 Infected Adults Aged ≥ 60 Years
- Status
- COMPLETED
- Phase
- PHASE3